Our Stanford Core Leadership Team and our External Advisors have expertise in a variety of content areas and medical specialties. Our advisors help to set the agenda for the Center as well as lead research projects, provide clinical care, and teach or mentor trainees all over the world.
Diana Chapman Walsh
President Emerita, Wellesley College and Senior Advisor, Stanford Global Health
Diana Chapman Walsh was the twelfth president of Wellesley College and is a recognized leader in higher education. Her presidency, from 1993-2007, was marked by educational innovation, including a revision of the curriculum and expanded programs in global education, the humanities, internships and service learning, interdisciplinary teaching and learning, and religious and spiritual life.
Dr. Walsh currently serves on the governing boards of the Kaiser Family Foundation and the Massachusetts Institute of Technology (and its executive committee). Her recent board service includes the Institute for Healthcare Improvement, the inaugural board of the Broad Institute of MIT and Harvard (which she chaired), and the Mind and Life Institute. Prior to the Wellesley presidency, Dr. Walsh was Florence Sprague Norman and Laura Stuart Norman Professor at the Harvard School of Public Health, where she chaired the Department of Health and Social Behavior. Before Harvard, she was a University Professor at Boston University and Professor of Social and Behavioral Sciences in the School of Public Health.
She has published and spoken widely on public health and higher education, and is a member of the American Academy of Arts and Sciences and the Center for Innovation in Global Health’s Climate Change and Health Initiative.
Cassia van der Hoof Holstein
Director of Global Health Equity, Emerson Collective and Senior Advisor, Stanford Global Health
Cassia van der Hoof Holstein is a Fellow of the Emerson Collective and a Senior Advisor to the Center for Innovation in Global Health at Stanford University’s School of Medicine. She chairs the Board of Directors of Plus 1, which connects recording artists, their audiences, and pragmatic social justice efforts, and serves on the Boards of Directors of the New Senior Investment Group (NYSE: SNR); PIVOT, a global health non-profit based Cassia van der Hoof Holstein is a Fellow of the Emerson Collective and a Senior Advisor to the Center for Innovation in Global Health at Stanford University’s School of Medicine. She chairs the Board of Directors of Plus 1, which connects recording artists, their audiences, and pragmatic social justice efforts, and serves on the Boards of Directors of the New Senior Investment Group (NYSE: SNR); PIVOT, a global health non-profit working to break cycles of poverty and disease in and beyond rural Madagascar; and Agile Global Health (formerly known as A&K Global Health LLC), a private global healthcare management company. She is a Trustee of Partners In Health and a member of the Advisory Board of the Community Outreach and Patient Empowerment (COPE) Program in the Navajo Nation.
Katherine States Burke
Senior Advisor and DCI Fellow, Former Deputy Director of Stanford Global Health
Katherine States Burke, MM, MSc, works to build cross-cutting teams to address global health problems. Educated at Harvard University, Ms. Burke began her career as a reporter, editor and publishing executive. After several years raising three boys, she returned to an early interest in health and earned a Master of Science in Global Health Sciences from the University of California, San Francisco. She also has a MM from the Kellogg School of Management at Northwestern University.
Prior to Stanford, Ms. Burke served as a Senior Fellow in Global Health Sciences at UCSF where she led the Centers of Excellence Project. She serves on the Board of Dean’s Advisers of the Harvard T.H. Chan School of Public Health.
Her interests include building research, training and health leadership capacity in low-resource settings.
Senior Advisor, Stanford Global Health
Herb Riband is an independent global healthcare advisor, working with a select group of startup companies, NGOs and academic professionals that are bringing truly innovative approaches to global health and healthcare delivery. He recently completed a 16-month fellowship at Stanford University’s Distinguished Careers Institute (DCI), which focused on global health and healthcare innovation. Prior to that, Herb had a diverse 31-year international career with leadership roles in multinational enterprises in biotechnology (Amgen), medical technology (Medtronic), consumer goods (Diageo), consulting (Ernst & Young) and law (Baker & McKenzie). He built international market access, healthcare policy, government affairs, strategic philanthropy, corporate communications and law functions for multinational corporations. In this regard, Herb led the launch of value-based healthcare delivery programs incorporating holistic “beyond the drug and device” solutions and promoting policies focused on measuring and improving patient health outcomes. He also built partnerships with health system stakeholders to accelerate patient access to appropriate biopharmaceutical and medical technology therapies, with a particular focus on non-communicable diseases (NCDs) like cancer, cardiovascular disease and diabetes. A native of Pennsylvania (USA), Herb received advanced degrees from Cornell University and the University of Michigan Law School. He is a citizen of the United States and Switzerland.